Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05442463

Hormone Therapy and Angiotensin-Dependent Arterial and Renal Vasoconstriction in Humans

Sponsor: University of Calgary

View on ClinicalTrials.gov

Summary

1. to investigate the association between route of administration of exogenous estrogen (transdermal vs. oral) and cardiorenal risk in cisgender (gender identity aligning with sex at birth) and transgender (gender identity not aligning with sex at birth) women. 2. to investigate the association between exogenous testosterone exposure and cardiorenal risk in cisgender (gender identity aligning with sex at birth) and transgender (gender identity not aligning with sex at birth) men.

Official title: Hormone Therapy and Angiotensin-Dependent Arterial and Renal

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

OBSERVATIONAL

Enrollment

200

Start Date

2020-11-30

Completion Date

2025-11-30

Last Updated

2025-03-27

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

Captopril Tablets

Captorpril challenge to each participant

DRUG

Iohexol

Iohexol infusion to evaluate measured GFR

Locations (1)

University of Calgary

Calgary, Alberta, Canada